Logo image of ALMKT.PA

MAUNA KEA TECHNOLOGIES (ALMKT.PA) Stock Fundamental Analysis

EPA:ALMKT - Euronext Paris - Matif - FR0010609263 - Common Stock - Currency: EUR

0.123  -0.01 (-5.38%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALMKT. ALMKT was compared to 59 industry peers in the Health Care Equipment & Supplies industry. ALMKT may be in some trouble as it scores bad on both profitability and health. ALMKT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALMKT has reported negative net income.
In the past year ALMKT has reported a negative cash flow from operations.
ALMKT had negative earnings in each of the past 5 years.
ALMKT had a negative operating cash flow in each of the past 5 years.
ALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

The Return On Assets of ALMKT (-64.04%) is worse than 89.83% of its industry peers.
Industry RankSector Rank
ROA -64.04%
ROE N/A
ROIC N/A
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMKT.PA Yearly ROA, ROE, ROICALMKT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

ALMKT has a Gross Margin of 31.67%. This is amonst the worse of the industry: ALMKT underperforms 81.36% of its industry peers.
ALMKT's Gross Margin has improved in the last couple of years.
ALMKT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
ALMKT.PA Yearly Profit, Operating, Gross MarginsALMKT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

ALMKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALMKT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALMKT has been increased compared to 5 years ago.
Compared to 1 year ago, ALMKT has a worse debt to assets ratio.
ALMKT.PA Yearly Shares OutstandingALMKT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALMKT.PA Yearly Total Debt VS Total AssetsALMKT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

ALMKT has an Altman-Z score of -5.58. This is a bad value and indicates that ALMKT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.58, ALMKT is doing worse than 84.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.58
ROIC/WACCN/A
WACC5.98%
ALMKT.PA Yearly LT Debt VS Equity VS FCFALMKT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 0.27 indicates that ALMKT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.27, ALMKT is doing worse than 89.83% of the companies in the same industry.
ALMKT has a Quick Ratio of 0.27. This is a bad value and indicates that ALMKT is not financially healthy enough and could expect problems in meeting its short term obligations.
ALMKT's Quick ratio of 0.14 is on the low side compared to the rest of the industry. ALMKT is outperformed by 89.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.14
ALMKT.PA Yearly Current Assets VS Current LiabilitesALMKT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

ALMKT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -114.81%.
Looking at the last year, ALMKT shows a very negative growth in Revenue. The Revenue has decreased by -26.96% in the last year.
ALMKT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.60% yearly.
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.77%
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%3.25%

3.2 Future

The Earnings Per Share is expected to grow by 81.66% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 35.72% on average over the next years. This is a very strong growth
EPS Next Y45%
EPS Next 2Y81.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year32.89%
Revenue Next 2Y35.72%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALMKT.PA Yearly Revenue VS EstimatesALMKT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M
ALMKT.PA Yearly EPS VS EstimatesALMKT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMKT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALMKT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMKT.PA Price Earnings VS Forward Price EarningsALMKT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMKT.PA Per share dataALMKT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3

4.3 Compensation for Growth

A more expensive valuation may be justified as ALMKT's earnings are expected to grow with 81.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y81.66%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALMKT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAUNA KEA TECHNOLOGIES

EPA:ALMKT (6/17/2025, 7:00:00 PM)

0.123

-0.01 (-5.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)10-02 2025-10-02
Inst Owners16.8%
Inst Owner ChangeN/A
Ins Owners0.98%
Ins Owner ChangeN/A
Market Cap7.96M
Analysts86.67
Price Target0.82 (566.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.12
BVpS-0.38
TBVpS-0.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.04%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.67%
FCFM N/A
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.86%
Cap/Sales 2.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.14
Altman-Z -5.58
F-Score3
WACC5.98%
ROIC/WACCN/A
Cap/Depr(3y)16.65%
Cap/Depr(5y)36.4%
Cap/Sales(3y)2.78%
Cap/Sales(5y)7.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.77%
EPS Next Y45%
EPS Next 2Y81.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%3.25%
Revenue Next Year32.89%
Revenue Next 2Y35.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-594.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-475.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-738.73%
OCF growth 3YN/A
OCF growth 5YN/A